Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Puerarin inhibits hyperglycemia-induced inter-endothelial junction through suppressing endothelial Nlrp3 inflammasome activation via ROS-dependent oxidative pathway
Dawei Lian, Huiqi Yuan, Xiong-Zhang Yin, et al.
Phytomedicine (2018) Vol. 55, pp. 310-319
Closed Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

NLRP3 inflammasome in endothelial dysfunction
Baochen Bai, Yanyan Yang, Qi Wang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 354
Flavonoids improve type 2 diabetes mellitus and its complications: a review
Xinrui Yi, Mosi Dong, Naifei Guo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 49
Puerarin inhibited oxidative stress and alleviated cerebral ischemia-reperfusion injury through PI3K/Akt/Nrf2 signaling pathway
Qianqian Zhang, Min Yao, Jiajia Qi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 47
Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Bowen Yang, Yumeng Lin, Yibo Huang, et al.
Redox Biology (2024) Vol. 70, pp. 103032-103032
Open Access | Times Cited: 21
Endothelial Dysfunction: Redox Imbalance, NLRP3 Inflammasome, and Inflammatory Responses in Cardiovascular Diseases
Cláudia Penna, Pasquale Pagliaro
Antioxidants (2025) Vol. 14, Iss. 3, pp. 256-256
Open Access | Times Cited: 2
Role of Thioredoxin-Interacting Protein in Diseases and Its Therapeutic Outlook
Naila Qayyum, Muhammad Haseeb, Moon Suk Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2754-2754
Open Access | Times Cited: 102
Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin
Di Wang, Tong Bu, Yangqian Li, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2121-2121
Open Access | Times Cited: 63
Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
Jingxue Ye, Lanfang Li, Min Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis
Yu Ding, Wenhua Li, Shi Peng, et al.
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 4, pp. 524-532
Open Access | Times Cited: 28
Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
Daniela Maria Tănase, Emilia Valasciuc, Evelina Maria Gosav, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8162-8162
Open Access | Times Cited: 27
Role of neutrophils in different stages of atherosclerosis
Xiao‐Jing Zhang, Zhanfang Kang, Dazhong Yin, et al.
Innate Immunity (2023) Vol. 29, Iss. 6, pp. 97-109
Open Access | Times Cited: 24
Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
Christian Bailly
Chemico-Biological Interactions (2020) Vol. 325, pp. 109124-109124
Closed Access | Times Cited: 66
Puerarin protects against myocardial ischemia/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: The role of the SIRT1/NF-κB pathway
Zikuan Wang, Rui-Rui Chen, Jinghua Li, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107086-107086
Closed Access | Times Cited: 63
Allicin alleviated acrylamide-induced NLRP3 inflammasome activation via oxidative stress and endoplasmic reticulum stress in Kupffer cells and SD rats liver
Bo Nan, Chaoyue Yang, Lu Li, et al.
Food and Chemical Toxicology (2020) Vol. 148, pp. 111937-111937
Closed Access | Times Cited: 56
Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway
Qi Liu, Rui Zuo, Kai Wang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 6, pp. 771-781
Open Access | Times Cited: 53
The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target
Alison Domingues, Julia Jolibois, Perrine Marquet de Rougé, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1693-1693
Open Access | Times Cited: 49
Molecular Mechanism of Puerarin Against Diabetes and its Complications
Yi-ling Bai, Lingling Han, Jun-Hui Qian, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 37
Edible Pueraria lobata-Derived Exosomes Promote M2 Macrophage Polarization
Jiaqi Wu, Xiaoyu Ma, Yu Lu, et al.
Molecules (2022) Vol. 27, Iss. 23, pp. 8184-8184
Open Access | Times Cited: 33
Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice
Meixi Lu, Jiyuan Yin, Tianshu Xu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117262-117262
Closed Access | Times Cited: 17
Effect of traditional Chinese medicine on gut microbiota in adults with type 2 diabetes: A systematic review and meta-analysis
Yujiao Zheng, Qiyou Ding, Yu Wei, et al.
Phytomedicine (2020) Vol. 88, pp. 153455-153455
Closed Access | Times Cited: 49
Puerarin induces Nrf2 as a cytoprotective mechanism to prevent cadmium-induced autophagy inhibition and NLRP3 inflammasome activation in AML12 hepatic cells
Zhao-Ming Yu, Xuemei Wan, Min Xiao, et al.
Journal of Inorganic Biochemistry (2021) Vol. 217, pp. 111389-111389
Closed Access | Times Cited: 41
Thioredoxin-interacting protein (TXNIP) as a target for Alzheimer’s disease: flavonoids and phenols
Meng Zhang, Guanhua Hu, Nan Shao, et al.
Inflammopharmacology (2021) Vol. 29, Iss. 5, pp. 1317-1329
Closed Access | Times Cited: 35
Targeting NLRP3 Inflammasome in the Treatment Of Diabetes and Diabetic Complications: Role of Natural Compounds from Herbal Medicine
Ying Bai, Qianqian Mu, Xueli Bao, et al.
Aging and Disease (2021) Vol. 12, Iss. 7, pp. 1587-1587
Open Access | Times Cited: 35
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Kai Ding, Chao Song, Heng-Jing Hu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 24
Rosmarinic acid inhibits oxLDL-induced inflammasome activation under high-glucose conditions through downregulating the p38-FOXO1-TXNIP pathway
Jean Baptiste Nyandwi, Gyung Hyuck Ko, Hana Jin, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114246-114246
Closed Access | Times Cited: 38
Page 1 - Next Page

Scroll to top